| Cannabinoid actions on neural stem cells: implications for pathophysiology RS Rodrigues, DM Lourenço, SL Paulo, JM Mateus, MF Ferreira, ... Molecules 24 (7), 1350, 2019 | 53 | 2019 |
| S100B inhibition protects from chronic experimental autoimmune encephalomyelitis C Barros, A Barateiro, A Neto, B Soromenho, AP Basto, JM Mateus, ... Brain Communications 4 (3), fcac076, 2022 | 9 | 2022 |
| Neurogenesis and gliogenesis: relevance of adenosine for neuroregeneration in brain disorders JM Mateus, FF Ribeiro, M Alonso-Gomes, RS Rodrigues, JM Marques, ... Journal of Caffeine and Adenosine Research 9 (4), 129-144, 2019 | 7 | 2019 |
| Unravelling a novel role for cannabidivarin in the modulation of subventricular zone postnatal neurogenesis DM Lourenço, R Soares, S Sá-Santos, JM Mateus, RS Rodrigues, ... European Journal of Pharmacology 959, 176079, 2023 | 3 | 2023 |
| Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress RS Rodrigues, JB Moreira, JM Mateus, A Barateiro, SL Paulo, SH Vaz, ... Translational Psychiatry 14 (1), 170, 2024 | 1 | 2024 |
| Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration MJ Nunes, AN Carvalho, J Reis, D Costa, M Moutinho, J Mateus, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1870 (3), 166993, 2024 | 1 | 2024 |
| Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer’s Disease Model SL Paulo, L Ribeiro-Rodrigues, RS Rodrigues, JM Mateus, ... Journal of Alzheimer's Disease 82 (3), 1183-1202, 2021 | | 2021 |
